Article citationsMore>>

Williams, B., MacDonald, T.M,, Morant, S., et al. (2015) Spironolactone versus Placebo, Bisoprolol, and Doxazosin to Determine the Optimal Treatment for Drug-Resistant Hypertension (PATHWAY-2): A Randomised, Double-Blind, Crossover Trial. Lancet, 386, 2059-2068.
https://doi.org/10.1016/S0140-6736(15)00257-3

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top